Has Tara McGahey received payments from drug or device companies?

Yes. Drug and device makers reported $20,859 in general payments to Tara McGahey across 890 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tara McGahey did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tara McGahey come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tara McGahey

Nurse Practitioner · Naples, FLNPI 1467486357

Payments from drug & device makers

$20,859in general payments, 2019–2025

Across 890 payments — averaging $23.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$3K
Incyte Corporation$1K
E.r. Squibb & Sons, L.L.C.$1K
Pfizer$1K
Merck$1K
Bristol Myers Squibb$982
plus $12K from 54 others

What the payments were for

Food & beverage$20,66699%
Education$1931%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	93	$2,501
Incyte Corporation	48	$1,357
E.r. Squibb & Sons, L.L.C.	57	$1,304
Pfizer	57	$1,217
Merck	45	$1,102
Bristol Myers Squibb	43	$982
Novartis	54	$952
GSK	25	$773
Johnson & Johnson	38	$736
Daiichi Sankyo Inc.	25	$674
Regeneron Healthcare Solutions, Inc.	22	$618
Seagen Inc.	32	$558
Eisai Inc.	21	$477
Genentech USA, Inc.	25	$475
Beigene USA, Inc.	18	$437
Sanofi	17	$430
Sobi, Inc	18	$427
Lilly USA, LLC	14	$378
Gilead(2 entities)	16	$373
Takeda Pharmaceuticals U.S.A., Inc.	13	$366
Myriad Genetic Laboratories, Inc.	11	$346
Array Biopharma Inc	17	$314
AbbVie	15	$301
Jazz Pharmaceuticals Inc.	9	$284
Bayer	14	$276
Amgen	15	$257
Astellas Pharma US Inc	7	$222
Servier Pharmaceuticals LLC	8	$193
Rigel Pharmaceuticals, Inc.	3	$148
Tersera Therapeutics LLC	5	$147
Geron Corporation	5	$141
Kyowa Kirin, Inc.	6	$138
ADC Therapeutics America, Inc.	7	$136
Boehringer Ingelheim	5	$128
AVEO Pharmaceuticals, Inc.	6	$106
CTI Biopharma Corp.	5	$104
Beone Medicines USA, Inc.	4	$91
Acrotech Biopharma Inc.	4	$78
Alnylam Pharmaceuticals Inc.	3	$75
Pharmacosmos Therapeutics Inc.	3	$72
Genmab U.S., Inc.	3	$68
Puma Biotechnology, Inc.	4	$68
Syndax Pharmaceuticals, Inc.	3	$67
Deciphera Pharmaceuticals Inc.	3	$66
Pharmacyclics LLC, An Abbvie Company	3	$61
Epizyme, Inc.	3	$60
Morphosys, US Inc.	3	$58
Sumitomo Pharma America, Inc.	3	$57
Recordati_rare_diseases_inc.	2	$52
Stemline Therapeutics Inc.	2	$52
Dova Pharmaceuticals	3	$52
Myovant Sciences Inc.	3	$50
EMD Serono, Inc.	2	$50
Fennec Pharmaceuticals, Inc.	2	$50
Taiho Oncology, Inc.	3	$48
G1 Therapeutics, Inc.	2	$45
Ipsen Biopharmaceuticals, Inc	2	$44
Adaptive Biotechnologies Corporation	2	$35
Agios Pharmaceuticals, Inc.	2	$35
Pharmaessentia USA Corporation	1	$31

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LYNPARZA$246
JAKAFI$231
myRisk$146
ENJAYMO$134
DATROWAY$125
Tavalisse$123
Enhertu$122
ZEPZELCA$119
Reblozyl$117
TAGRISSO$113
OJJAARA$113
OPDIVO$112

How this compares

$20,859 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamoxifen Citrate	34	$1,115
Anastrozole	56	$839
Letrozole	13	$175
Potassium Chloride	13	$93

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Naples

Stephanie SimmermanNaples$283K
Doreen CassarinoNaples$41K
Jolanta BaginskiClearwater$494K
Adissa PerezWinter Park$370K
April WessonTampa$342K
Margarita FernandezMiami$311K
Claudette WalkerPonte Vedra Beach$271K
Lisa NodzonTampa$246K
Ashima BahlTampa$226K
Maya BloombergMiami$202K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →